Home
Cancer types
Treatments
Support
News
Centres and oncologists
Search
Tuesday, November 10, 2026
Ogkologos.com
Home
Cancer types
Treatments
Support
News
Centres and oncologists
Home
World News
Page 38
World News
World News
ΕΠΙΣΤΗΜΟΝΙΚΑ ΝΕΑ
ΖΩΝΤΑΣ ΜΕ ΚΑΡΚΙΝΟ
ΚΑΡΚΙΝΟΣ
ΚΕΝΤΡΑ ΚΑΡΚΙΝΟΥ – ΟΓΚΟΛΟΓΟΙ
Myths and Facts
ΝΕΑ - ΤΥΠΟΙ ΚΑΡΚΙΝΟΥ
ΤΥΠΟΙ ΚΑΡΚΙΝΟΥ
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
FDA Approves Pembrolizumab and Berahyaluronidase alfa-pmph for Subcutaneous Injection
Ogkologos
-
October 2, 2025
0
Study presents an AI-guided approach to target cancer antigens
Ogkologos
-
October 1, 2025
0
Efficacy of ICI Combined with Chemotherapy in Patients with Advanced Penile...
Ogkologos
-
October 1, 2025
0
Low-Dose Adjuvant Aspirin Decreases Incidence of Recurrence Among Patients with Resected...
Ogkologos
-
September 30, 2025
0
HER2 Is Not a Predictive Biomarker of Benefit From Up-front Chemotherapy...
Ogkologos
-
September 29, 2025
0
EMA Recommends Granting a Marketing Authorisation for Elinzanetant
Ogkologos
-
September 26, 2025
0
ESMO Calls on EU Research Ministers to Prioritise Cancer Research Funding...
Ogkologos
-
September 25, 2025
0
AI is impacting cancer care, but also the environment
Ogkologos
-
September 25, 2025
0
FDA Approves Selumetinib for Paediatric Patients 1 Year of Age and...
Ogkologos
-
September 25, 2025
0
Weekly Cisplatin-Based Chemoradiotherapy Improves RFS and OS, Although Not Statistically Significant,...
Ogkologos
-
September 24, 2025
0
1
...
37
38
39
...
432
Page 38 of 432
MOST POPULAR
Sun Exposure Lowers Risk of Breast Cancer, Study Finds
January 6, 2022
Spending Review 2020 – Steps in the right direction, but opportunities...
November 25, 2020
Health inequalities: “We have a moral duty to reduce them”
February 15, 2022
Καρκίνος και Κορωνοϊός (COVID-19) ΜΕΡΟΣ Α
April 1, 2021
Load more
HOT NEWS
More Evidence that Ruxolitinib Benefits Some Patients with Graft-Versus-Host Disease
Science Surgery: ‘How are children’s cancers different from adult’s cancers?’
EMA Recommends Granting a Marketing Authorisation for Poherdy
Giredestrant plus everolimus prolongs PFS among patients with ER-positive, HER2-negative, ESR1-mutated...
Ελληνικά
English (UK)